S. J. Jacobus | No disclosures Contributions: ABCDE |
S. Kumar | Clinical Trial Support - Celgene, Millennium, Genzyme, Novartis, Cephalon; Consultant Merck Contributions: ABCDE |
S.A. Van Wier | No disclosures Contributions: AC |
G.J. Ahmann | No disclosures Contributions: AC |
K.J. Henderson | No disclosures Contributions: AC |
N.S. Callander | No disclosures Contributions: ABCD |
M.E. Williams | Celgene clinical trial research funding; consultant and Member of a Celgene clinical trial Data Safety Committee (total compensation <$10,000). Cephalon, Genentech, Millennium, Novartis: clinical trial research funding. Contributions: A |
D.S. Siegel | Celgene Honoraria/Speakers Bureau/Research Support Millennium Honoraria/Speakers Bureau; Onyx-Honoraria Contributions: A |
P.R. Greipp | No disclosures Contributions: ABCDE |
S.V. Rajkumar | No disclosures Contributions: ABCDE |
H. Uno | No disclosures Contributions: ABCDE |
R. Fonseca | Patent for prognostication of MM based on genetic categorization of the disease. Consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS and Amgen. Research funding from Cylene, Onyx. Contributions: ABCDE |